BlackRock, Inc. 13D and 13G filings for Actinium Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-16 7:02 pm Sale | 2025-06-30 | 13G | Actinium Pharmaceuticals, Inc. ATNM | BlackRock Inc. BLK | 462,969 1.500% | -1,228,945 (-72.64%) | Filing |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | Actinium Pharmaceuticals, Inc. ATNM | BlackRock Inc. BLK | 1,691,914 6.200% | 1,691,914 (New Position) | Filing |